Halberd Update on WatchDawg® PTSD Treatment
02 déc. 2024 08h00 HE
|
Halberd Corp.
Halberd Update on WatchDawg® PTSD Treatment
MAPS Successfully Clears Path for Cannabis Research through FDA Formal Dispute
20 nov. 2024 12h40 HE
|
Multidisciplinary Association for Psychedelic Studies (MAPS)
After three years of negotiation with the FDA, MAPS has successfully secured FDA clearance to conduct a clinical trial, MJP2, to examine the use of smoked cannabis for the treatment of PTSD symptoms...
electroCore Donates gammaCore Sapphire for Real World Evaluation of nVNS in Trauma Among Israelis
19 nov. 2024 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., Nov. 19, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it has donated 20 gammaCore...
PharmAla Reaches Agreement in Principle to Supply MDMA to Clinical Trial in Exchange for Full Data License
14 nov. 2024 09h20 HE
|
PharmAla Biotech
PharmAla reaches agreement in principle to trade with a clinical trial to trade its LaNeo MDMA for a data license to the trial outcomes.
Aviv Clinics Unveils Compelling Results on Treatment for Veterans Suffering from Post-Traumatic Stress Disorder
13 nov. 2024 08h52 HE
|
Aviv Clinics
ORLANDO, Fla., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Aviv Clinics, one of the most advanced brain health clinics in the world, shares the results of a groundbreaking study revealing a specialized...
PharmAla to supply LaNeo MDMA for Clinical Trial at Yale
07 nov. 2024 09h20 HE
|
PharmAla Biotech
PharmAla to supply Yale University with MDMA for clinical trial
$3.8 Million Department of Defense Grant Awarded for Groundbreaking Study on Safe and Sound Protocol in PTSD Treatment
10 oct. 2024 10h00 HE
|
Unyte Health
The study aims to determine if filtered music as an adjunct therapy can reduce PTSD symptoms and enhance treatment for civilian and military populations.
PharmAla to supply the University of Texas, San Antonio, with novel dosage form of LaNeo™ MDMA
08 oct. 2024 08h55 HE
|
PharmAla Biotech
PharmAla signs contract to develop novel dosage form of LaNeo MDMA, to be used in clinical trial at University of Texas San Antonio
American Addiction Centers Names Navy Veteran as New VP of Military and Veteran Affairs
03 oct. 2024 13h47 HE
|
American Addiction Centers, Inc.
BRENTWOOD, Tenn., Oct. 03, 2024 (GLOBE NEWSWIRE) -- In an effort to increase access to care for Veterans, American Addiction Centers (AAC) has appointed Sazha Alexandra Ramos as its new Vice...
Halberd Partnership Secures Contract from Defense Atomics Corporation to Address Brain Injury and PTSD
11 sept. 2024 08h00 HE
|
Halberd Corp.
Halberd Partnership Secures Contract from Defense Atomics Corporation to Address Brain Injury and PTSD